je.st
news
Lilly angles for arthritis blockbuster
2016-03-26 22:04:04| Biotech - Topix.net
And now, the waiting begins. Within six months, Eli Lilly and Co. could know whether the Food and Drug Administration has approved its latest drug, baricitinib, a once-a-day tablet for treating rheumatoid arthritis - a market poised to grow to $80 billion by 2020.
Tags: angles
arthritis
lilly
blockbuster
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||